The SETH study showed a trend toward reduced severity of COVID-19 pneumonia in patients taking tacrolimus, but it was not statistically significant [ 12 , 13 ] Both studies demonstrated that stopping immunosuppressive therapies had no survival benefit.
← all excerpts
Acute Biventricular Heart Failure After COVID-19 Infection in an Orthotropic Heart Transplant Patient: A Case Report.
1
—
—